Health

Pfizer and Flagship Partner to Develop New Obesity Treatments

Jun 12, 2024 1 min read

Jump to Summary

Flagship Pioneering and ProFound Therapeutics have announced an exploration agreement to identify potential first-in-class therapies for obesity, leveraging ProFound's proprietary ProFoundry™ Platform. This initiative marks the first exploration agreement under Flagship's Pioneering Medicines strategic partnership with Pfizer, which was announced in July 2023. Both Flagship and Pfizer will contribute $50 million each to develop up to 10 programs, with the potential for each program to yield up to $700 million.

The collaboration is part of a broader effort to address the growing obesity market, which is anticipated to reach sales of $125.3 billion by 2033, driven primarily by the rise of anti-obesity drugs. GlobalData projects the obesity population in major pharmaceutical markets, including the US and several European countries, to grow at an annual rate of 0.57%, reaching over 161.5 million cases by 2033. The partnership allows Pfizer the option to advance selected research programs identified by ProFound's platform, aiming to accelerate the development of innovative medicines for obesity.

#tech #biotech #business #finance #markets #startups

Summary

Other news in health

GSK Acquires Full Rights for COVID and Flu Vaccines from CureVac in New Restructured Deal

CureVac N.V. has announced a strategic restructuring to focus on high-value mRNA projects in oncology and other areas of unmet medical need. This restructuring includes reducing its workforce by approximately 30% to streamline operations and enhance its focus on technology innovation, research, and development. The move follows a new

Tori Spelling, 51, Flaunts Figure in Neon Bikini After Weight-Loss Drug Admission

Actress Tori Spelling, 51, has recently shared details about her weight loss journey following the birth of her son, Beau. Spelling revealed that she used diabetes medications, Ozempic and Mounjaro, to shed the baby weight, attributing her difficulty in losing weight to her age. She mentioned that she had never

EU Greenlights First Targeted COPD Therapy, Dupixent

Sanofi and Regeneron have received European Union approval for their Dupixent injection for the treatment of chronic obstructive pulmonary disease (COPD), a condition primarily affecting cigarette smokers. This approval marks a rare instance of the EU clearing a drug faster than the United States, where the U.S. Food and

Kazakh Opposition Journalist Sadykov Dies in Kyiv Following Assassination Attempt

Kazakh opposition journalist Aidos Sadykov has died in Ukraine after being shot in the head on June 18 in Kyiv. Sadykov, who was in a coma following the attack, passed away in the hospital. His wife, Natalya Sadykova, confirmed his death and has accused Kazakh President Kassym-Jomart Tokayev of being